Further to the intimation given by the Company dated 13th November, 2024, with regard to US FDA inspection at Company’s manufacturing facility located at Baddi, Himachal Pradesh. FDC has informed that the Company has received final approval from US FDA for the Company’s Abbreviated New Drug Application (ANDA) for Cefixime 400 mg Tablets.
The above information is a part of company’s filings submitted t o BSE.